Sinopharm Tech Holdings Limited provided group earnings guidance for the three months ended 30 September 2019. The board of directors of the company inform the shareholders of the company and potential investors that, based on information that is currently available to the management of the company and the preliminary review of the Group's unaudited management accounts, the Group's loss attributable to equity holders of the company for the three months ended 30 September 2019 is expected to decrease significantly by over 60%, as compared to the corresponding period in 2018. The significant decrease in loss was mainly attributable to an increase of revenue by over 800% for the three months ended 30 September 2019, as compared to the corresponding period in 2018 which contributed from the Group's internet plus solution and supply chain services business.